What Is Morphine? Drug Class, Schedule & Drug Test Answers
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026
Quick answer: Morphine is a Natural opioid agonist. Schedule II. Here's how the drug is classified, whether it's a narcotic/controlled substance, and what that means for testing.
What is Morphine?
Drug class: Natural opioid agonist
Federal schedule: Schedule II.
Morphine anchors the classic opiate panel. Hospital IV/PCA use creates the same positives as pills — bring discharge paperwork for the MRO.
Is Morphine a narcotic?
It is classified as a narcotic under the DEA's federal schedule. What matters more for you: Schedule II..
Does it show up on drug tests?
Yes — it is on the standard federal 5-panel. See the full Morphine drug test guide for detection windows and cutoffs.
False-positive caution
- Poppy-seed true positives (dietary); cutoffs calibrated for it.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Does Morphine Show up in a Drug Test?
Yes — Morphine appears on standard drug panels. Full guide →
How Long Has Morphine Been Around?
How long Morphine stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
How to Pass a Drug Test for Morphine?
Evidence-based ways to pass a drug test for Morphine — realistic timelines, what works, what backfires, and dilution flags to avoid. Full guide →
Morphine Drug Test Guide: Panels, Detection Windows & More?
Complete Morphine drug test guide: which panels detect it, urine/hair/saliva/blood detection windows, cutoff levels and prescription verification. Full guide →
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)